Cherry Creek Investment Advisors, Inc. Novo Cure LTD Transaction History

Cherry Creek Investment Advisors, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 24, 2023	SELL	$56.44 - $118.81 $156,338 - $329,103	-2,770 Reduced 41.59%	3,890 $233,000
Q3 2022 Oct 24, 2022	BUY	$67.99 - $89.57 $13,597 - $17,914	200 Added 3.1%	6,660 $506,000
Q2 2022 Jul 20, 2022	BUY	$56.6 - $89.9 $8,490 - $13,485	150 Added 2.38%	6,460 $449,000
Q1 2022 Apr 22, 2022	BUY	$60.15 - $84.52 $33,383 - $46,908	555 Added 9.64%	6,310 $523,000
Q3 2021 Nov 01, 2021	SELL	$116.17 - $194.55 $23,234 - $38,910	-200 Reduced 3.36%	5,755 $669,000
Q2 2021 Aug 13, 2021	BUY	$130.4 - $225.58 $776,532 - $1.34 Million	5,955 New	5,955 $1.32 Million

262

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.86B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Cherry Creek Investment Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Cherry Creek Investment Advisors, Inc. with notifications on news.